NCT00004065 Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer Status COMPLETED Phase PHASE1
NCT00003930 Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00003824 S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer Status TERMINATED Phase PHASE3
NCT00003779 Biological Therapy in Treating Patients With Bladder Cancer Status COMPLETED Phase PHASE3
NCT00003759 AD 32 With or Without BCG After Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder Cancer Status COMPLETED Phase PHASE2
NCT00003725 Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer Status UNKNOWN Phase PHASE3
NCT00003701 Combination Chemotherapy in Treating Patients With Bladder Cancer Status COMPLETED Phase PHASE3
NCT00003642 Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder Cancer Status TERMINATED Phase PHASE2
NCT00003640 Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer Status TERMINATED Phase PHASE2
NCT00003623 High-Dose Multivitamins Compared to a Placebo in Preventing the Recurrence of Cancer in Patients With Early Stage Bladder Cancer Status COMPLETED Phase PHASE3
NCT00003376 Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium Status COMPLETED Phase PHASE3
NCT00003342 Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer Status COMPLETED Phase PHASE1
NCT00003175 Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer Status COMPLETED Phase PHASE2
NCT00003133 Combination Chemotherapy Following Surgery in Treating Patients With Advanced Bladder Cancer Status COMPLETED Phase PHASE1
NCT00003129 Chemotherapy in Treating Patients With Early-Stage Bladder Cancer Status COMPLETED Phase PHASE2
NCT00003105 Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer Status COMPLETED Phase PHASE1/PHASE2